AAAS and the Food and Drug Law Institute (FDLI) are holding three 2-day meetings in Washington DC on personalized medicine, addressing the scientific discoveries, business models, and policy changes that are necessary to develop personalized treatments and diagnostics. All three meetings will be available via a free live webcast where viewers can use response technology to interact with speakers and session chairs.
The first meeting is June 1-2, and the agenda is available online. One session, "State of the Science: Connecting Biomarkers and Diagnostics" is chaired by Teri Manolio, who will be speaking at the CHGR's June 10 Retreat. Other sessions include topics about consumer genetics in the open market, ELSI issues, and other topics.
Personalized medicine: Planning for the Future
June 1-2 2009: Colloquium I Agenda